ClinicalTrials.gg
RecruitingNCT07174180Updated Jun 16, 2026

The Impact of Wearing the Hijab on Whole-body Heat Loss During Exercise-heat Stress

An interventional study of Exercise-heat stress with no hijab and Exercise-heat stress with a hijab in Heat Stress and Temperature Change, Body, sponsored by University of Ottawa. Recruiting at 1 site in Canada. Open to female participants aged 18 Years to 35 Years, including healthy volunteers. Per ClinicalTrials.gov, last updated 2026-06-16.

Sponsored by University of Ottawa · Not applicable, Interventional, and Basic science

From the registry’s dates

  • Started Jun 2025; still recruiting 1 year 4 months later.
Phase
Not applicable
Study type
Interventional
Enrollment
12
Allocation
Randomized
Ages
18 Years to 35 Years
Sex
Female
01

Study summary

The hijab (headscarf and cloak) is a Muslim dress, which covers the head, neck and chest, and conceals the female hair, leaving the face uncovered. It is worn by Muslim women worldwide including young Muslim women engaging in sports and exercise. As with any clothing worn on the body, the hijab can impact heat dissipation during exercise, potentially leading to increased body temperature and discomfort, especially in warmer environments. However, the extent to which the hijab may restrict heat loss remains unclear. This study aims to assess dry and evaporative heat exchange in young women performing moderate-intensity intermittent exercise in dry heat conditions (40°C, 15% relative humidity).

02

Conditions studied

  • Heat Stress
  • Temperature Change, Body

Keywords

  • Core temperature
  • Exercise
  • Females
  • Garment
  • Heat strain
  • Thermoregulation
  • Hot weather
03

In context

Heat Stress Disorders

118 studies on the registry are indexed under Heat Stress Disorders; 45 are open to participants now.

This study's planned enrollment of 12 is below the median of 24 across 104 interventional studies indexed under Heat Stress Disorders.

Browse Heat Stress Disorders studies →

Lead sponsor

University of Ottawa is the lead sponsor of 125 studies on the registry; 34 are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
18 Years to 35 Years
Sexes eligible
Female
Accepts healthy volunteers
Yes

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • healthy young female (18-35 years)
  • non smoking
  • English or French speaking
  • ability to provide

Exclusion criteria

Exclusion Criteria:

  • claustrophobia
  • engaged in endurance training
  • acute or chronic illness
  • sedentary (not engaged in any form of physical activity)
  • physical restriction limiting physical activity
Terms in these criteria, in plain language(1)

Underlined terms in the criteria open these too. Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.

Informed consent

Before you join, the study team explains what taking part involves — its purpose, what happens, the risks and possible benefits — and answers your questions, so you can decide freely. Consent is usually recorded on a form (the informed consent form, ICF) signed by you or, where the law allows, by someone legally authorised to decide for you.

You can keep asking questions during the study, you are told of new information that matters, and you can choose to leave at any time.

05

Study design

Phase
Not applicable
Primary purpose
Basic science
Allocation
Randomized
Intervention model
Crossover assignment
Masking
Single (Participant)
Enrollment
12 participants (estimated)

Study arms

  • Experimental
    No hijab

    Participants rest in a thermoneutral resting condition for 30-min (baseline resting) while wearing a cotton t-shirt and shorts, after which they enter a chamber regulated at 40°C where they perform an intermittent exercise bout consisting of two, 30-min moderate-intensity exercise bouts (fixed rate of heat production of 200 W/m2), with each exercise bout separated by a 15 min rest break and a 60-min recovery following the second exercise bout.

    Other: Exercise-heat stress with no hijab

  • Experimental
    Hijab

    Participants rest in a thermoneutral resting condition for 30-min (baseline resting) while wearing a hijab over cotton t-shir and shorts, after which they enter a chamber regulated at 40°C where they perform an intermittent exercise bout consisting of two, 30-min moderate-intensity exercise bouts (fixed rate of heat production of 200 W/m2), with each exercise bout separated by a 15 min rest break and a 60-min recovery following the second exercise bout.

    Other: Exercise-heat stress with a hijab

Interventions

  • OtherExercise-heat stress with no hijab

    Participants perform exercise in the heat with no hijab

  • OtherExercise-heat stress with a hijab

    Participants perform exercise in the heat with a hijab

06

What researchers measure

Primary outcomes

  1. Evaporative heat loss at end exercise

    Evaporative heat loss as assessed using a direct air calorimeter

    Time frame: End of the 60-min intermittent exercise bout

  2. Dry heat loss at end exercise

    Dry heat loss as assessed using a direct air calorimeter

    Time frame: End of the 60-min intermittent exercise bout

  3. Total heat loss at end exercise

    Total heat loss as assessed using a direct air calorimeter

    Time frame: End of the 60-min intermittent exercise bout

  4. Body heat storage

    Heat stored in the body for each of the exercise bouts

    Time frame: End of the 60-min intermittent exercise bout

  5. Change in body heat content

    Body heat content measured at the end of intermittent exercise

    Time frame: End of the 60-min intermittent exercise bout

  6. Core temperature

    Rectal temperature during final 5 minutes of each of the exercise bouts

    Time frame: End of the 60-min intermittent exercise bout

  7. Mean skin temperature

    Mean skin temperature during final 5 minutes of each of the exercise bouts

    Time frame: End of the 60-min intermittent exercise bout

  8. Relative change in core temperature at end exercise

    Relative increase in core temperature for each 30-minute exercise bout

    Time frame: End of the 60-min intermittent exercise bout

  9. Relative change in mean skin temperature at end exercise

    Relative change in mean skin temperature for each 30-minute exercise bout

    Time frame: End of the 60-min intermittent exercise bout

  10. Heart rate

    Heart rate during final 5 minutes of each of the exercise bouts

    Time frame: End of the 60-min intermittent exercise bout

  11. Rating of perceived exertion

    Perceived exertion assessed via a self-report questionnaire upon verbal prompting (scale is as follows: 6: indicating the participant is not exerting themselves at all with 20 indicating participant is exerting themselves maximally)

    Time frame: End of the 60-min intermittent exercise bout

  12. Thermal sensation A

    Thermal sensation assessed via a self-report questionnaire upon verbal prompting (scale is as follows: 7-point scale; -3 indicating the participant is cold to +3 indicating the participant is hot)

    Time frame: End of the 60-min intermittent exercise bout

  13. Thermal sensation B

    Thermal sensation assessed via a self-report questionnaire upon verbal prompting (scale is as follows: 7-point scale; 0 indicating the participant is neutral to 7 indicating the participant is extremely hot)

    Time frame: End of the 60-min intermittent exercise bout

  14. Thirst sensation

    Thirst sensation assessed via a self-report questionnaire upon verbal prompting (scale is as follows: 9-point scale; 1 indicating the participant is not thirsty at all to 9 indicating the participant is very, very thirsty)

    Time frame: End of the 60-min intermittent exercise bout

07

Study locations

1 of 1 sites recruiting
08

Timeline

Tracking since Sep 25, 2026
ElapsedEstimatedEstimated, not yet reachedSimilar studies: half by the dot; the band is the middle halfHalf of similar studies reached it by the dot; the band is the middle half, from a quarter to three quarters

Ran from Jun 2025 to primary completion in Oct 2025, 4 months.

Of 75 non-industry interventional studies with no phase under Heat Stress Disorders, half reached primary completion within 16 months of starting (the median), counting those still running; a quarter within 4 and three quarters within 27. This study's 4 months is below that.

Counting every sponsor, half of 75 studies reached it within 16 months; a quarter within 4 and three quarters within 27.

How these figures are worked out, and which studies are left out of them.

Registered
Aug 15, 2025
First posted
Sep 15, 2025
StartActual
Jun 13, 2025
Primary completionActual
Oct 16, 2025
CompletionEst.
Dec 31, 2026
Last update
Jun 16, 2026
What these dates mean
Start.
When the first participant enrolled; while estimated, when the study expects to open to recruitment.
Primary completion.
When the last participant was examined or treated to collect data for the study's main question, its primary outcome. A study that stopped early gives the date its data collection stopped.
Completion.
When the last participant's last visit took place, for every outcome, secondary ones and side effects included: the end of the study. Often later than primary completion, sometimes the same day.
Actual and Est.
Actual means the registry says the date has happened. Est. (estimated) is a date the sponsor plans or expects. It can still move, and the sponsor is expected to change it to actual once it has passed.
No changes since tracking began. The registry record was last updated on Jun 16, 2026, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
09

Registry details

Key details

Study ID
NCT07174180
Responsible party
Glen P. Kenny (Full Professor, University Research Chair, University of Ottawa) — Principal investigator
First posted
Sep 15, 2025
Start date
Jun 13, 2025
Primary completion
Oct 16, 2025
Completion
Dec 31, 2026 (estimated)
Last update
Jun 16, 2026

Study contacts

Glen P Kenny, PhD
Contact
gkenny@uottawa.ca
6135625800 ext. 4282
Glen P Kenny, PhD
principal investigator · University of Ottawa

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Interested in this study?

Eligibility is decided by the study team. Share this record with your doctor or contact the team directly.

Contact study team

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion